TMG's EBITDA grows to $103.3m in FY23 | Healthcare Asia Magazine
, Singapore

TMG's EBITDA grows to $103.3m in FY23

Its Singapore segment revenue was driven by higher bill sizes.

SGX-listed Thomson Medical Group (TMG) posted a EBITDA of $355.8m for FY 2023, higher than $109.7m in FY 2022 due to lower income project-related services.

It was also cushioned by the reduced government grant, according to its financial report.

READ MORE: Thomson Medical Group EBITDA soars 41% in H1 

The hospital group's net profit after tax was $41.1m in FY 2023 from $58.6m in FY 2022.

TMG's revenue in 2023 went up 6.6% from 2022 as patient count rises and healthcare spending increases.

The hospital segment grew 14.6% whilst in Singapore higher average bill sizes also rose.

"We remain focused on our plans to expand and enhance our medical centres and clinics in Singapore, including a multi-year asset enhancement initiative of our flagship hospital in Singapore," read the statement.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!